North Korea steals $300 million USD in cryptocurrency for nuclear weapons – UN report

South Africa’s rollout of AstraZeneca’s Covid-19 vaccine has been put on pause following reports that it only provides “minimal protection” for the new strain of the virus first detected in South Africa. The country will continue plans to administer the Pfizer-BioNTech vaccine and the Johnson & Johnson vaccine.

The AstraZeneca vaccine, developed in partnership with Oxford University, only provides limited protection against the mild variant of Covid-19 detected in South Africa known as B.1.351, according to early data from a trial. South Africa Minister of Health Zweli Mkhize says immunisations using the AstraZeneca vaccine would be put on hold while scientists review the vaccine.

The study was done on 2,000 volunteers who were an average age of 31. Half the group received the vaccine and half received a placebo. A news release from the University of the Witwatersand…